MHB018A Treatment in Patients With Active Thyroid Eye Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

MHB018A Treatment in Patients With Active Thyroid Eye Disease — Stella

Recruiting

Back to Thyroid Associated Ophthalmopathies trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality

Key details

Phase

Large-scale testing

Sponsor

Minghui Pharmaceutical (Hangzhou) Ltd

Enrollment target

~108 participants

Started

July 2025

Primary completion

July 2026

Age range

18 Years – 75 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov